One Iron Street,
Boston , MA, 02210
Boston , MA, 02210
Summary
The fund seeks to replicate the total return performance of the benchmark index, before fees and expenses, by investing in companies in the United States.
The investment process starts with a list of companies in the benchmark index and the research team utilizes quantitative techniques and fundamental analysis to identify investment opportunities.
Next, the research team invests significantly in the securities comprising t More
Webiste
Directors
Sep 12, 2023- Sandra G. Sponem
- Dwight D. Churchill
- Gunjan Chauhan
- Carolyn M. Clancy
- Carl G. Verboncoeur
- James E. Ross
- Clare S. Richer
- Kristi L. Rowsell
Chief Compliance Officer
- Brian Harris
Price
- $ 44.7 ( -0.8 )
-
Feb 03, 2025Last Close
- Net Assets
-
$222.6M
Feb 27, 2024
- 52-Week High/Low
- $48.3 - $39.1
- Expense Ratio
- -
Performance
YTD
0%
3 Year
4%
5 Year
-2.8%
Best
118.12%
2000
Worst
-23.2%
2016
Company Name |
Holding |
State Street Global Advisors | 5.69 % |
Axsome Therapeutics Inc | 4.27 % |
Viatris Inc | 4.08 % |
Eli Lilly & Co | 4.02 % |
Zoetis Inc | 3.97 % |
Pfizer Inc | 3.97 % |
Organon & Co | 3.96 % |
Catalent Inc | 3.96 % |
Intra-Cellular Therapies Inc | 3.95 % |
Bristol-Myers Squibb Co | 3.94 % |
More | 3.94 % |
Documents
NAV
2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | ||
---|---|---|---|---|---|---|---|---|---|---|---|
XPH | 0% | -3.2% | 1.6% | -10.3% | -11.5% | 13% | 24.9% | -15.3% | 12.1% | -23.2% | |
S&P 500 | 1.9% | 23.3% | 24.2% | -19.4% | 27.3% | 16.2% | 28.9% | -6.2% | 19.4% | 9.5% |
2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
q1 | 0% | 3.6% | 0.2% | -0.8% | -3.5% | -21% | 13.7% | -3.7% | 7.1% | -21.4% | ||||
q2 | 0% | -1.5% | -0.1% | -7.2% | 4% | 19.2% | -4.4% | 6.9% | 3.1% | 4% | ||||
q3 | 0% | 0% | -3% | -4.4% | -9.8% | 0.8% | -11% | 12.7% | -1% | 5.9% | ||||
q4 | 0% | 0% | 6.2% | 2% | -2.3% | 19.1% | 27.7% | -21.7% | 0% | -11.3% |
Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
2025 | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
2024 | 0.9% | 5.8% | -2.9% | -7.7% | 1.3% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |